Financials Econ Healthcare (Asia) Limited
Equities
EHG
SGXE59069307
Healthcare Facilities & Services
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.193 SGD | -2.03% | -1.53% | -5.85% |
Apr. 19 | Econ Healthcare Appoints R&T Corporate Services as New Continuing Sponsor | MT |
Mar. 06 | Econ Healthcare Completes Acquisition of Ambulance Services Provider | MT |
Valuation
Fiscal Period: March | 2022 | 2023 |
---|---|---|
Capitalization 1 | 69.39 | 48.83 |
Enterprise Value (EV) 1 | 93.3 | 70.85 |
P/E ratio | 196 x | 10.1 x |
Yield | 0.81% | 3.53% |
Capitalization / Revenue | 1.78 x | 1.12 x |
EV / Revenue | 2.39 x | 1.63 x |
EV / EBITDA | 17.5 x | 8.61 x |
EV / FCF | 10,159,552 x | 13,454,045 x |
FCF Yield | 0% | 0% |
Price to Book | 1.95 x | 1.26 x |
Nbr of stocks (in thousands) | 257,000 | 257,000 |
Reference price 2 | 0.2700 | 0.1900 |
Announcement Date | 7/5/22 | 5/26/23 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Net sales 1 | 37.49 | 38.2 | 39.01 | 43.54 |
EBITDA 1 | 6.627 | 4.755 | 5.316 | 8.229 |
EBIT 1 | 5.617 | 3.631 | 3.937 | 6.752 |
Operating Margin | 14.98% | 9.51% | 10.09% | 15.51% |
Earnings before Tax (EBT) 1 | 4.356 | 6.827 | 0.8607 | 5.63 |
Net income 1 | 4.037 | 5.7 | 0.3501 | 4.849 |
Net margin | 10.77% | 14.92% | 0.9% | 11.14% |
EPS 2 | 0.0195 | 0.0275 | 0.001376 | 0.0189 |
Free Cash Flow | - | 8.12 | 9.183 | 5.266 |
FCF margin | - | 21.26% | 23.54% | 12.09% |
FCF Conversion (EBITDA) | - | 170.78% | 172.73% | 63.99% |
FCF Conversion (Net income) | - | 142.45% | 2,622.89% | 108.6% |
Dividend per Share | - | 0.007800 | 0.002200 | 0.006700 |
Announcement Date | 7/13/21 | 7/13/21 | 7/5/22 | 5/26/23 |
Income Statement Evolution (Quarterly data)
Fiscal Period: March | 2022 S1 |
---|---|
Net sales | - |
EBITDA | - |
EBIT | - |
Operating Margin | - |
Earnings before Tax (EBT) | - |
Net income 1 | 1.612 |
Net margin | - |
EPS 2 | 0.006300 |
Dividend per Share | - |
Announcement Date | 11/9/21 |
Balance Sheet Analysis
Fiscal Period: March | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Net Debt 1 | 32.7 | 23 | 23.9 | 22 |
Net Cash position 1 | - | - | - | - |
Leverage (Debt/EBITDA) | 4.935 x | 4.843 x | 4.497 x | 2.676 x |
Free Cash Flow | - | 8.12 | 9.18 | 5.27 |
ROE (net income / shareholders' equity) | - | 24.2% | -0.18% | 11.2% |
ROA (Net income/ Total Assets) | - | 3.26% | 2.84% | 4.22% |
Assets 1 | - | 174.6 | 12.34 | 114.9 |
Book Value Per Share 2 | 0.0900 | 0.1200 | 0.1400 | 0.1500 |
Cash Flow per Share 2 | 0.0400 | 0.0800 | 0.1000 | 0.1000 |
Capex 1 | 1.89 | 2.44 | 2.63 | 3.63 |
Capex / Sales | 5.04% | 6.39% | 6.74% | 8.34% |
Announcement Date | 7/13/21 | 7/13/21 | 7/5/22 | 5/26/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.85% | 38.7M | |
+18.41% | 83.07B | |
-29.08% | 70.89B | |
+3.59% | 28.32B | |
-7.08% | 17.73B | |
+2.07% | 17.43B | |
+0.93% | 15.64B | |
+6.78% | 13.46B | |
+8.40% | 12.82B | |
+68.45% | 12.69B |
- Stock Market
- Equities
- EHG Stock
- Financials Econ Healthcare (Asia) Limited